Back to the bill

89th General Assembly · Iowa Funnel one-pager · Tuesday, November 10, 2026

HF 873: Relating to insurance coverage for prescription drugs used in the treatment of stage IV cancer, and including applicability provisions

Died when the session ended · The 2022 session adjourned on May 24, 2022, the General Assembly’s last regular session. Bills that didn’t pass both chambers died.

What it does

This bill relates to insurance coverage for prescription drugs used in the treatment of stage IV cancer. The bill requires policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs to provide coverage for prescription cancer drugs. “Prescription cancer drug” is defined in the bill as a prescription drug that is used to treat stage IV cancer. “Stage IV cancer” is also defined in the bill. The policy, contract, or plan is required to provide coverage, without imposing a step therapy protocol, for a prescription cancer drug that has been approved by the United States food and drug administration, the use of which is in accordance with medical standards of care for stage IV cancer, and the use of which is supported by peer-reviewed, evidence-based literature.

Sponsors

Not listed

Cost

No fiscal note

In plain words

  1. April 21, 2021Filed in the House and sent to the Commerce committee

From public records at legis.iowa.gov, compiled by Iowa Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Tuesday, November 10, 2026. https://iowafunnel.com/bills/89/HF873